trapped fourth ventricle
Recently Published Documents


TOTAL DOCUMENTS

50
(FIVE YEARS 7)

H-INDEX

11
(FIVE YEARS 1)

2021 ◽  
Vol 7 (3) ◽  
pp. 147
Author(s):  
Dimitrios Panagopoulos ◽  
Ploutarchos Karydakis ◽  
Marios Themistocleous

2020 ◽  
Vol 13 (4) ◽  
pp. 581-586
Author(s):  
P.E. Edison ◽  
S.K. Sanamandra ◽  
V.A. Shah ◽  
V.R. Baral ◽  
C.L. Yeo

Trapped fourth ventricle (TFV) as a complication of post-hemorrhagic hydrocephalus (PHH) is widely reported in the pediatric population with a prior history of ventriculo-peritoneal (VP) shunt placement. Characterized by disproportionate dilatation of the fourth ventricle on serial neuro-imaging, it is rarely encountered in the early course of preterm infants and the differentiating clinical features are subtle and non-specific. Clinical alertness and sonographic correlation hold the key to early diagnosis. We report an early emergence of TFV in an extremely low gestational age newborn (ELGAN) following fulminant Pseudomonas aeruginosa meningitis, approach to management, and the neurological outcome. Fourth ventricle entrapment as a complication of perinatally acquired Pseudomonas aeruginosa meningitis in a surviving ELGAN is extremely rare.


2020 ◽  
Vol 11 ◽  
pp. 393
Author(s):  
Ahmed Abdelaziz Elsharkawy ◽  
Hytham Elatrozy

Background: Trapped fourth ventricle (TFV) usually develops as a complication of supratentorial ventricular CSF shunting, especially when hydrocephalus is caused by intraventricular hemorrhage and/or infection. This study aimed to assess the feasibility of endoscopic aqueduct stenting using a single refashioned shunt tube to treat cases presenting with both TFV and shunt malfunction. Methods: We retrospectively collected and analyzed data from patients presenting with TFV and supratentorial shunt malfunction who underwent endoscopic aqueduct stenting using a refashioned shunt tube. All cases were treated at our institution between January 2010 and July 2019. The surgical technique is described. Results: Eighteen patients were enrolled in our study. There were ten males and eight females. The mean age was 11.2 years (range = 1–33 years). Headache, nausea, and vomiting were the most common clinical presentations. The mean duration of follow-up was 22.1 months (range = 6–60 months). All cases showed clinical and radiological improvement after surgery. Conclusion: Endoscopic antegrade aqueductoplasty and stenting with the refashioned panventricular shunt catheter are an adequate treatment option for both TFV and supratentorial shunt malfuncion.


2020 ◽  
Vol 36 (12) ◽  
pp. 2961-2969
Author(s):  
Ahmed El Damaty ◽  
Ahmed Eltanahy ◽  
Andreas Unterberg ◽  
Heidi Baechli

Abstract Purpose Trapped fourth ventricle (TFV) is a well-identified problem in hydrocephalic children. Patients with post-hemorrhagic hydrocephalus (PHH) are mostly affected. We tried to find out predisposing factors and describe clinical findings to early diagnose TFV and manage it. Methods We reviewed our database from 1991 to 2018 and included all patients with TFV who required surgery. We analyzed prematurity, cause of hydrocephalus, type of valve implanted, revision surgeries, modality of treatment of TFV, and their clinical examination and MRI imaging. Results We found 21 patients. Most of patients suffered from PHH (16/21), tumor (2/21), post-meningitis hydrocephalus (2/21), and congenital hydrocephalus (1/21). Seventeen patients were preterm. Seven patients suffered from a chronic overdrainage with slit ventricles in MRI. Thirteen patients showed symptoms denoting brain stem dysfunction; in 3 patients, TFV was asymptomatic and in 5 patients, we did not have available information regarding presenting symptoms due to missing documentation. An extra fourth ventricular catheter was the treatment of choice in 18/21 patients. One patient was treated by cranio-cervical decompression. Endoscopic aqueductoplasty with stenting was done in last 2 cases. Conclusion Diagnosis of clinically symptomatic TFV and its treatment is a challenge in our practice of pediatric neurosurgery. PHH and prematurity are risk factors for the development of such complication. Both fourth ventricular shunting and endoscopic aqueductoplasty with stenting are effective in managing TFV. Microsurgical fourth ventriculostomy is not recommended due to its high failure rate. Early detection and intervention may help in avoiding fatal complication and improving the neurological function.


2020 ◽  
Vol 162 (10) ◽  
pp. 2441-2449 ◽  
Author(s):  
Gaurav Tyagi ◽  
Prashant Singh ◽  
Dhanajaya I. Bhat ◽  
Dhaval Shukla ◽  
Nupur Pruthi ◽  
...  

2020 ◽  
Vol 15 (1) ◽  
pp. 45-50
Author(s):  
Michael Vaca ◽  
Erick Vásquez ◽  
Daniel Vásquez ◽  
Andy Zavaleta ◽  
Jonathan Vargas ◽  
...  

2017 ◽  
Vol 39 ◽  
pp. 101-103 ◽  
Author(s):  
Neelan J. Marianayagam ◽  
Netanel Ben Shalom ◽  
Saeed Yassin ◽  
Shalom Michowiz ◽  
Sagi Harnof ◽  
...  

2017 ◽  
Vol 36 (01) ◽  
pp. 71-74
Author(s):  
Vinod Kumar ◽  
Ajay Hegde ◽  
Rajesh Nair ◽  
Girish Menon

AbstractFourth ventricular dilatation is usually seen along with tri-ventriculomegaly in patients with communicating hydrocephalus. Isolated fourth ventricular dilatation is uncommon, especially as a sequelae following infective or post hemorrhagic communicating hydrocephalus. Communicating hydrocephalus is reported in vestibular schwannoma with an incidence of 3.7 to 23.5%, but 4th ventricular dilatation following its treatment has not been reported in the literature. We report a novel case of isolated fourth ventricular obstruction following surgery for recurrent vestibular schwannoma and ventriculoperitoneal shunt placement for communicating hydrocephalus. Management strategies range from endoscopic procedures to ventricular shunt placement. We describe the surgical technique for the placement of a fourth ventricular shunt with the use of a Y connector.


Sign in / Sign up

Export Citation Format

Share Document